Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 221

Similar articles for PubMed (Select 24494635)

1.

An update on new and emerging therapies for relapsing-remitting multiple sclerosis.

Weinstock-Guttman B.

Am J Manag Care. 2013 Nov;19(17 Suppl):s343-54. Review.

2.

Oral disease-modifying therapies for relapsing-remitting multiple sclerosis.

Thomas RH, Wakefield RA.

Am J Health Syst Pharm. 2015 Jan 1;72(1):25-38. doi: 10.2146/ajhp140023. Review.

PMID:
25511835
3.

Efficacy and safety of BG-12 (dimethyl fumarate) and other disease-modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison.

Hutchinson M, Fox RJ, Havrdova E, Kurukulasuriya NC, Sarda SP, Agarwal S, Siddiqui MK, Taneja A, Deniz B.

Curr Med Res Opin. 2014 Apr;30(4):613-27. doi: 10.1185/03007995.2013.863755. Epub 2013 Nov 26. Review.

PMID:
24195574
4.

Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis.

Filippini G, Del Giovane C, Vacchi L, D'Amico R, Di Pietrantonj C, Beecher D, Salanti G.

Cochrane Database Syst Rev. 2013 Jun 6;6:CD008933. doi: 10.1002/14651858.CD008933.pub2. Review.

PMID:
23744561
5.

New management algorithms in multiple sclerosis.

Sorensen PS.

Curr Opin Neurol. 2014 Jun;27(3):246-59. doi: 10.1097/WCO.0000000000000096. Review.

PMID:
24759080
6.

Teriflunomide for multiple sclerosis.

He D, Xu Z, Dong S, Zhang H, Zhou H, Wang L, Zhang S.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD009882. doi: 10.1002/14651858.CD009882.pub2. Review.

PMID:
23235682
7.

Emerging therapies in relapsing-remitting multiple sclerosis.

Marriott JJ, O'Connor PW.

Rev Recent Clin Trials. 2010 Sep;5(3):179-88. Review.

PMID:
20500147
8.

New and Emerging Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: What is New and What is to Come.

Nicholas J, Morgan-Followell B, Pitt D, Racke MK, Boster A.

J Cent Nerv Syst Dis. 2012 May 16;4:81-103. doi: 10.4137/JCNSD.S6692. Print 2012.

9.
10.

Update on multiple sclerosis treatments.

Bridel C, Lalive PH.

Swiss Med Wkly. 2014 Sep 23;144:w14012. doi: 10.4414/smw.2014.14012. eCollection 2014. Review.

11.

Comparing the cost-effectiveness of disease-modifying drugs for the first-line treatment of relapsing-remitting multiple sclerosis.

Goldberg LD, Edwards NC, Fincher C, Doan QV, Al-Sabbagh A, Meletiche DM.

J Manag Care Pharm. 2009 Sep;15(7):543-55.

12.

Drug Class Review: Disease-modifying Drugs for Multiple Sclerosis: Final Update 1 Report [Internet].

Smith B, Carson S, Fu R, McDonagh M, Dana T, Chan BKS, Thakurta S, Gibler A.

Portland (OR): Oregon Health & Science University; 2010 Aug.

13.

[Emerging therapies for multiple sclerosis].

de Lorenzo-Pinto A, Rodríguez-González CG, Ais-Larisgoitia A.

Med Clin (Barc). 2013 Jan 19;140(2):76-82. doi: 10.1016/j.medcli.2012.05.008. Epub 2012 Jul 4. Review. Spanish.

PMID:
22766059
14.

Fingolimod: a review of its use in the management of relapsing-remitting multiple sclerosis.

Scott LJ.

CNS Drugs. 2011 Aug;25(8):673-98. doi: 10.2165/11207350-000000000-00000. Review.

PMID:
21790210
15.

Current and future therapies for multiple sclerosis.

Minagar A.

Scientifica (Cairo). 2013;2013:249101. doi: 10.1155/2013/249101. Epub 2013 Feb 7. Review.

16.

Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.

Wingerchuk DM, Carter JL.

Mayo Clin Proc. 2014 Feb;89(2):225-40. doi: 10.1016/j.mayocp.2013.11.002. Review.

PMID:
24485135
17.

Current management of relapsing-remitting multiple sclerosis.

Sedal L, Wilson IB, McDonald EA.

Intern Med J. 2014 Oct;44(10):950-7. doi: 10.1111/imj.12558. Review.

PMID:
25302718
18.

Oral treatment for multiple sclerosis.

Killestein J, Rudick RA, Polman CH.

Lancet Neurol. 2011 Nov;10(11):1026-34. doi: 10.1016/S1474-4422(11)70228-9. Review.

PMID:
22014437
19.

Impact of diagnosis and early treatment on the course of multiple sclerosis.

Noyes K, Weinstock-Guttman B.

Am J Manag Care. 2013 Nov;19(17 Suppl):s321-31. Review.

20.

Rituximab for relapsing-remitting multiple sclerosis.

He D, Guo R, Zhang F, Zhang C, Dong S, Zhou H.

Cochrane Database Syst Rev. 2013 Dec 6;12:CD009130. doi: 10.1002/14651858.CD009130.pub3. Review.

PMID:
24310855
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk